Showing results (81-90 of 326) with videos related to
Sort By:
Pageof 33
CNS Spectrums|December 20, 2015
Cognitive impairment in schizophrenia: the great unmet needRalph Aquila, Leslie CitromeNeuropsychiatric Disease and Treatment|January 31, 2019
Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapyKristen Ward, Leslie CitromeCNS Spectrums|February 28, 2014
The psychopharmacology of violence: making sensible decisionsLeslie Citrome, Jan VolavkaExpert Opinion on Investigational Drugs|June 28, 2022
AXS-05: an investigational treatment for Alzheimer's disease-associated agitationKristen Ward, Leslie CitromeClinical Schizophrenia & Related Psychoses|January 13, 2016
Brexpiprazole for the Treatment of Schizophrenia: A Review of this Novel Serotonin-Dopamine Activity ModulatorJoseph McEvoy, Leslie CitromeExpert Opinion on Drug Metabolism & Toxicology|December 21, 2017
Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorderKristen Ward, Leslie CitromeHarvard Review of Psychiatry|August 31, 2002
Optimal dosing of atypical antipsychotics in adults: a review of the current evidenceLeslie Citrome, Jan VolavkaExpert Review of Neurotherapeutics|July 2, 2008
Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risksLeslie Citrome, Joshua KantrowitzExpert Review of Neurotherapeutics|October 9, 2009
Atypical antipsychotics: revolutionary or incremental advance?Leslie Citrome, Jan VolavkaPageof 33